NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









GeneproDX

GeneproDX

Private
SantiagoHealthcare & Life Scienceshttps://geneprodx.com/

Last Round

VC Round

Feb 14, 2022

Est. Valuation

$135M

Total Funding Raised

$1.4M

Company Overview

GeneproDX is a molecular diagnostics company that develops genomic tests, including the ThyroidPrint assay, to aid in the management of patients with indeterminate thyroid nodules.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Usage-Based SaaS

AI Layer

Application

Keywords

molecular diagnosticsthyroid cancergene expressionprecision medicinethyroid noduleclinical decision supportbiotechdiagnostic testoncologyliquid biopsyneural networkmRNA expressiondiagnostic assaymedtechgenomics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GeneproDX Comparables

Compare GeneproDX with similar companies based on industry and business-model similarity.

GeneproDX comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Biocartis
85%
Veracyte
74%
Interpace Biosciences, Inc.
72%

GeneproDX Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 14, 2022
VC RoundJun 21, 2021
VC RoundApr 17, 2018
Series ADec 12, 2017

GeneproDX Investors

Notable investors and investment history

GeneproDX investors
InvestorRounds
VenturanceSeries A
Endurance InvestmentsSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 11, 2025

    Monthly visitors increased 276% MoM, reaching 955.

  • Dec 12, 2017

    $1.4M round led by Venturance

GeneproDX Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

GeneproDX Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GeneproDX's valuation, stock price, and market status.

Firmographic Details

HeadquartersSantiago
Employee Range17
Year Founded2014
Last FundingFeb 14, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.